CARD8
protein-codingcaspase recruitment domain family member 8, the group of Caspase recruitment domain containing
Gene summary
The protein encoded by this gene belongs to the caspase recruitment domain (CARD)-containing family of proteins, which are involved in pathways leading to activation of caspases or nuclear factor kappa-B (NFKB). This protein may be a component of the inflammasome, a protein complex that plays a role in the activation of proinflammatory caspases. It is thought that this protein acts as an adaptor molecule that negatively regulates NFKB activation, CASP1-dependent IL1B secretion, and apoptosis. Polymorphisms in this gene may be associated with a susceptibility to rheumatoid arthritis. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, May 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~75.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0033643
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Gastrointestinal
Intervention: Allergy/Immunology/Infectious; Gastrointestinal
Rationale: The condition can involve sequelae of inflammatory bowel disease, and medical management (eg, with steroids, anti-IL1B monoclonal antibodies) have been described as beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CARD8 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001184900.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 91 | 7 | 102 | ||
| missense | 234 | 12 | 6 | 252 | ||
| nonsense | 7 | 7 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 1 | 21 | 22 | |||
| splice donor/acceptor (+/-2bp) | 9 | 1 | 10 | |||
| Total | 0 | 1 | 277 | 104 | 13 | 395 |
Highest pathogenic variant AF is 0.000027348522
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001171829.1 | 11 | MANE Select | |
| Ensembl | ENSP00000499211.1 | 11 | MANE Select | |
| RefSeq | NP_001171830.1 | 10 | Standard | |
| RefSeq | NP_001171831.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- NOD-like receptor signaling pathway - Homo sapiens (human)
- Nucleotide-binding Oligomerization Domain (NOD) pathway
Biological Process
- apoptotic process
- activation of cysteine-type endopeptidase activity involved in apoptotic process
- negative regulation of tumor necrosis factor-mediated signaling pathway
- negative regulation of lipopolysaccharide-mediated signaling pathway
- negative regulation of NF-kappaB transcription factor activity
Molecular Function
- protein binding
- cysteine-type endopeptidase activator activity involved in apoptotic process
- NACHT domain binding
- protein homodimerization activity
- CARD domain binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- cytosol
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000391898
- Coding exons
- 11
- Length
- 75177
- Individuals with no LoFs
- 125632
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 112
- Defined
- 125746
- p
- 0.000453
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.923 | 251 | 296 | 0.849 | 0.0000162 | 3520 |
| Missense (PolyPhen) | 84 | 96.456 | 0.87087 | 1225 | ||
| Synonymous | 0.178 | 112 | 114 | 0.979 | 0.00000617 | 1019 |
| Loss of Function | 2.01 | 13 | 23.5 | 0.552 | 0.00000109 | 287 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00065 | 0.00065 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00011 | 0.000097 | rare |
| South Asian | 0.0030 | 0.0029 | notable |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Inhibits NF-kappa-B activation. May participate in a regulatory mechanism that coordinates cellular responses controlled by NF-kappa-B transcription factor. May be a component of the inflammasome, a protein complex which also includes PYCARD, NALP2 and CASP1 and whose function would be the activation of proinflammatory caspases.;
Recessive Scores
- pRec
- 0.0634
Intolerance Scores
- LoFtool
- 0.983
- RVIS EVS
- 1.18
- RVIS percentile EVS
- 92.79
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.783
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |